This is a preview of subscription content, log in via an institution to check access.
Referenties
Cusi C, Cantisani TA, Celani MG et al. Cochrane Neurological Network. Galantamine for Alzheimer’s disease and mild cognitive impairment. Neuroepidemiology 2007;28:116-7.
Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer’s disease. Am J Med 2007;120:388-97.
Iliffe S. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer’s disease. CNS Drugs 2007;21:177-84.
Jann MW, Shirley KL, Small GW. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet 2002;41:719-39.
Liepelt I, Maetzler W, Blaicher HP et al. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 2007;23:351-67.
Websites
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Bohn Stafleu van Loghum, Houten
About this chapter
Cite this chapter
Rikkert, M.G.M.O., Verhey, F.R.J. (2007). Dementiesyndroom. In: Het Geriatrie formularium.. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-6431-2_36
Download citation
DOI: https://doi.org/10.1007/978-90-313-6431-2_36
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-5003-2
Online ISBN: 978-90-313-6431-2
eBook Packages: Dutch language eBook collection